# Cytophenix

> Cytophenix is an Australian medical technology company developing Cytophenix FloCAST™, a rapid antimicrobial susceptibility testing (AST) platform that delivers same-day results — approximately 4 hours from positive blood culture — to guide antibiotic treatment for bloodstream infections and help combat antimicrobial resistance. Headquartered in Perth, Western Australia.

Cytophenix FloCAST™ combines acoustic flow cytometry with AI-driven analysis to produce phenotypic AST results 48–72 hours faster than conventional methods. The platform is For Research Use Only (RUO) — not yet cleared for in vitro diagnostic use.

## Company

- [About Cytophenix](https://cytophenix.com/about): Team, mission, and company history.
- [Careers](https://cytophenix.com/careers): Open positions and how to apply.
- [Contact](https://cytophenix.com/contact): Contact details for general, investor, partnership, and media enquiries.
- [Acknowledgement of Country](https://cytophenix.com/acknowledgement-of-country): Acknowledgement of the Whadjuk people of the Noongar nation.

## Product — Cytophenix FloCAST™

- [Cytophenix FloCAST™ overview](https://cytophenix.com/flocast): Rapid antimicrobial susceptibility testing platform — how it works, panels, and time-to-result.
- [Clinical Outcomes](https://cytophenix.com/flocast/clinical): Clinical evidence, studies, and patient outcomes for same-day AST.
- [Laboratory Workflow](https://cytophenix.com/flocast/laboratory): Laboratory integration, sample workflow, and turnaround times.
- [Health Economics](https://cytophenix.com/flocast/financial): Cost, reimbursement, and antimicrobial stewardship impact.

## Why it matters

- [Sepsis Kills](https://cytophenix.com/sepsis): The clinical burden of sepsis and why time-to-appropriate-antibiotic matters.
- [Preserving Antibiotics](https://cytophenix.com/preserving-antibiotics): Antimicrobial resistance (AMR) and how rapid AST supports stewardship.

## Research & Media

- [Literature Library](https://cytophenix.com/literature): Peer-reviewed publications, posters, and presentations (gated).
- [Press Releases](https://cytophenix.com/press): Company news, announcements, and media coverage.
- [Investor Relations](https://cytophenix.com/investors): Information for current and prospective investors.

## Legal

- [Privacy Policy](https://cytophenix.com/privacy-policy)
- [Terms of Service](https://cytophenix.com/terms-of-service)

## Key facts

- Product: Cytophenix FloCAST™ — rapid antimicrobial susceptibility testing (AST).
- Time to result: approximately 4 hours from positive blood culture.
- Technology: acoustic flow cytometry with AI-based analysis.
- Regulatory status: For Research Use Only (RUO). Not FDA cleared.
- Headquarters: Perth, Western Australia, Australia.
- Legal name: Cytophenix Pty Ltd.
- LinkedIn: https://www.linkedin.com/company/cytophenix/